SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital has sold Certara to Arsenal Capital Partners. Certara’s model-based drug development and data analytics software enables its biopharmaceutical customers to significantly improve productivity and decision-making throughout the entire drug development value chain, from early molecular discovery through complex and costly pre-clinical and clinical development.
Help employers find you! Check out all the jobs and post your resume.
